ICD-10 Coding for Muscular Dystrophy(G12.9U, G71.0, G71.01)
Comprehensive guide on ICD-10 coding for muscular dystrophy, including Duchenne and Becker types. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Muscular Dystrophy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G71.01 | Duchenne or Becker muscular dystrophy | Use when genetic testing confirms Duchenne or Becker muscular dystrophy. |
|
| G71.02 | Facioscapulohumeral muscular dystrophy | Use when clinical presentation matches facioscapulohumeral muscular dystrophy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMuscular Dystrophy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Muscular Dystrophy.
Failing to document genetic testing results.
Impact
Clinical: Leads to misdiagnosis or inappropriate treatment., Regulatory: Increases risk of audit., Financial: May result in denied claims.
Mitigation
Ensure genetic testing is performed and results are documented., Train staff on documentation requirements.
Using unspecified codes when specific type is known.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit due to lack of specificity., Data Quality: Reduces accuracy of patient records.
Mitigation
Ensure genetic testing results are reviewed and documented to specify the type of muscular dystrophy.
Use of unspecified codes
Impact
High risk of audit when unspecified codes are used without genetic confirmation.
Mitigation
Require genetic testing for all suspected cases of muscular dystrophy.